Of even more concern is that loss-of-function mutations in human SLC13A5/INDY/Mindy do not lead to resistance to type 2 diabetes and instead cause neonatal epilepsy and several other developmental defects (Kopel et al., 2021). This evidence concerns the gene SLC13A5 and epilepsy.